<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9411">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05698381</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00017204</org_study_id>
    <nct_id>NCT05698381</nct_id>
  </id_info>
  <brief_title>Daily Vinegar Ingestion and Metabolic Health</brief_title>
  <official_title>Effect of Daily Vinegar Ingestion for Four Weeks on Mood State, Inflammatory State, and Risk for Metabolic Syndrome in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if vinegar ingestion promotes beneficial changes to&#xD;
      metabolic health parameters in healthy, overweight adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent research, in animal and human subjects, suggests that vinegar intake is inversely&#xD;
      associated with insulin resistance, mood states and depression, inflammation, and other&#xD;
      disease parameters. The study will be conducted as a randomized controlled trial in&#xD;
      overweight adults to further examine these relationships and possible mechanisms. Although&#xD;
      the mechanisms are not known, research suggests that changes in the gut microbiome, a&#xD;
      response to the ingestion of the postbiotic acetic acid, may factor into the beneficial&#xD;
      effects of vinegar ingestion. Through analyses of blood, changes in key blood metabolites&#xD;
      associated with mood states (e.g., gamma-aminobutyric acid) as well as markers of gut health&#xD;
      (e.g., LPS binding protein) and inflammation (e.g., CRP) will be assessed. Additionally mood&#xD;
      state will be assessed using validated measures and determine risk for metabolic syndrome, a&#xD;
      cluster of risk factors associated with many chronic conditions. It is hypothesized that&#xD;
      vinegar ingestion will promote beneficial changes to these health parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2023</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>liquid vinegar (contains active dose of acetic acid) vinegar pill (contains only a trace of acetic acid)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Depression score</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>Patient Health Questionnaire (PHQ-9); scores range from 0 (none-minimal) to 27 (severe)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Depression score</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>Center for Epidemiologic Studies Depression Scale (CES-D); scores range from 0 to 60 (higher scores suggest a greater presence of depressive symptoms. A score of 15 or higher is interpreted to indicate a risk for depression).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gamma-aminobutyric acid (GABA)</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>Blood levels of the neurotransmitter GABA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>metabolic syndrome</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>A cluster of conditions that increase risk of heart disease, stroke and type 2 diabetes: increased blood pressure, high blood sugar, waist circumference, and abnormal cholesterol or triglyceride levels. siMS score = 2*Waist/Height + Gly/5.6 + Tg/1.7 + TAsystolic/130-HDL/1.02 or 1.28 (for male or female subjects, respectively) (adapted from Soldatovic et al. (2016) siMS Score: Simple Method for Quantifying Metabolic Syndrome. PLoS ONE 11(1): e014614)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>Blood C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LPS</measure>
    <time_frame>change from baseline at week 4</time_frame>
    <description>Blood Lipopolysaccharide binding protein</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Inflammation</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Liquid vinegar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 tablespoons BID per day (3000 mg acetic acid)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 vinegar pills per day (30 mg acetic acid)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Liquid vinegar</intervention_name>
    <description>2 tablespoons consumed twice daily with meals</description>
    <arm_group_label>Liquid vinegar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vinegar pill</intervention_name>
    <description>2 pills consumed upon waking</description>
    <arm_group_label>Vinegar pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  non-smoker&#xD;
&#xD;
          -  free of chronic disease by self-report&#xD;
&#xD;
          -  able to speak, read, and understand English&#xD;
&#xD;
          -  able to consent.&#xD;
&#xD;
          -  BMI ≥ 25 and ≤ 35&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  adherence to specific diets for weight loss&#xD;
&#xD;
          -  vegetarian&#xD;
&#xD;
          -  report GERD or regular heartburn&#xD;
&#xD;
          -  unwilling to consume vinegar daily for 4 weeks&#xD;
&#xD;
          -  pregnant or lactating women&#xD;
&#xD;
          -  recreational drug use, alcohol intake above recommendations (1 drink/day for women, 2&#xD;
             drinks/day for men - or none)&#xD;
&#xD;
          -  competitive level physical training (e.g., physical activity above recommendations as&#xD;
             set by the Physical Activity Guidelines for Americans)&#xD;
&#xD;
          -  scoring 1 or higher on question 9 of the PHQ-9 questionnaire.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol S Johnston, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carol S Johnston, PhD</last_name>
    <phone>4808387127</phone>
    <email>carol.johnston@asu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>850 PBC</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol S Johnston, PhD</last_name>
      <phone>602-965-2539</phone>
      <email>carol.johnston@asu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>January 16, 2023</study_first_submitted>
  <study_first_submitted_qc>January 16, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2023</study_first_posted>
  <last_update_submitted>April 23, 2023</last_update_submitted>
  <last_update_submitted_qc>April 23, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arizona State University</investigator_affiliation>
    <investigator_full_name>Carol Johnston</investigator_full_name>
    <investigator_title>Professor and Associate Dean</investigator_title>
  </responsible_party>
  <keyword>vinegar</keyword>
  <keyword>acetic acid</keyword>
  <keyword>LPS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

